Combination therapy with SGLT2 inhibitors for diabetic kidney disease
Author:
Funder
National Natural Science Foundation of China
Nature Science Foundation of Jiangxi Province
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference66 articles.
1. The european renal association - european Dialysis and transplant association (ERA-EDTA) registry annual report 2015: a summary;Kramer;Clin. Kidney J.,2018
2. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017;Roth;Lancet,2018
3. The sodium/glucose cotransport family SLC5;Wright;Pflugers Arch.,2004
4. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications;Gerich;Diabet. Med.,2010
5. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia;DeFronzo;Diabetes Obes. Metab.,2012
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Management of Type II DM in patients Showing Progressive Increase in the Creatinine Level – A Cross-sectional Study;Research Journal of Pharmacy and Technology;2024-06-25
2. SGLT2 Inhibitors and Diabetic Kidney Disease: Targeting Multiple and Interrelated Signaling Pathways for Renal Protection;Current Molecular Pharmacology;2023-11-28
3. Benefits and harms of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2‐I) and renin–angiotensin–aldosterone system inhibitors (RAAS‐I) versus SGLT2‐Is alone in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials;Endocrinology, Diabetes & Metabolism;2021-10-12
4. New progress in drugs treatment of diabetic kidney disease;Biomedicine & Pharmacotherapy;2021-09
5. Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk;Cardiovascular Diabetology;2020-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3